N Square Lifesciences Llp
About N Square Lifesciences Llp
Data last updated: 13 February 2026
N Square Lifesciences Llp is a limited liability partnership company based in Secunderabad, Telangana, India. It specialises in real estate advisory and brokerage, a part of the broader real estate and construction sector. Incorporated on 12 April 2021, the LLP has been in operation for over 5 years.
Registered with ROC Hyderabad under LLPIN AAW-6711.
Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners Soham Satish Modi and Gaurang Jayantilal Mody.
Accounts filed on 31 March 2025. Office: 5.4.187/3 & 4 2Nd Floor Soham Mansion M.G. Road, Secunderabad, Telangana, India – 500003.
The LLP is associated with 1 brand - Modi Properties.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address5.4.187/3 & 4 2Nd Floor Soham Mansion M.G. Road, Secunderabad, Telangana, India – 500003
-
IndustryReal Estate and Construction, Real Estate Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with N Square Lifesciences Llp
N Square Lifesciences Llp operates one associated brand: Modi Properties. These brands represent N Square Lifesciences Llp's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Affordable homes are developed and brokerage services are provided. | modiproperties.com |
Competitors & Alternatives of N Square Lifesciences Llp
Brands and companies operating in the same space as N Square Lifesciences Llp include Anant Raj Group, NeoLiv, VBHC and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Offers real estate and infrastructure development services focused on commercial and residential projects | Delhi, India, India | 1969 |
|
|
Provider of tech-enabled integrated residential real estate property management solutions | Mumbai, India, India | 2023 |
|
|
Developer of residential real estate projects | Bengaluru, India, India | 2009 |
|
|
Developer of residential properties | Bengaluru, India, India | 2007 |
|
|
Real estate developer offering residential properties and plots in Chennai. | Chennai, India, India | 2004 |
|
|
Real estate developer specializing in affordable housing and luxury projects across India. | Gurugram, India, India | 2006 |
Designated Partners of N Square Lifesciences Llp
N Square Lifesciences Llp is currently managed by 2 designated partners, with 1 former designated partner having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Soham Satish Modi
Also directs:
Modi Realtors Gv Hyderabad Llp, Amtz Medpolis Healthcare Llp, Modi Housing Private Limited and 5 more
|
Designated Partner | 12 Apr 2021 | 5 Years 2 Months | Current |
|
Gaurang Jayantilal Mody
Also directs:
Villa Orchids Llp, Modi Farm House (Hyderabad) Llp, Serene Constructions Llp and 5 more
|
Designated Partner | 08 Apr 2024 | 2 Years 3 Months | Current |
Financials of N Square Lifesciences Llp FY 2025 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Charges & Borrowings N Square Lifesciences Llp
N Square Lifesciences Llp does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at N Square Lifesciences Llp
View historical data on people associated with N Square Lifesciences Llp, including employment history and EPFO contributions.
Employee Count & EPFO Data of N Square Lifesciences Llp
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of N Square Lifesciences Llp
GSTIN & GST Filing Data of N Square Lifesciences Llp
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for N Square Lifesciences Llp
Credit Ratings, Legal Cases & Regulatory Alerts of N Square Lifesciences Llp
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by N Square Lifesciences Llp
MSME Payment Delays by N Square Lifesciences Llp
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of N Square Lifesciences Llp
Subsidiaries & Group Companies of N Square Lifesciences Llp
See the full corporate group - holding company, subsidiaries, associates and joint ventures of N Square Lifesciences Llp with ownership details.
MCA Filings & Documents of N Square Lifesciences Llp
MCA Filings & Documents of N Square Lifesciences Llp
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on N Square Lifesciences Llp
Frequently Asked Questions about N Square Lifesciences Llp
N Square Lifesciences Llp is an active limited liability partnership in the real estate and construction sector based in Secunderabad, Telangana, India. It was incorporated on 12 April 2021 (5+ years old) and is registered under LLPIN AAW-6711.
The current designated partners of N Square Lifesciences Llp are:
The primary industry of N Square Lifesciences Llp is real estate and construction. The LLP specifically operates in real estate services. The LLP is currently active in this sector.
N Square Lifesciences Llp can be reached at the registered office: 5.4.1873 & 4 2Nd Floor Soham Mansion M.G. Road, Secunderabad, Telangana, India – 500003.
The total obligation of contribution is ₹1 Lakh.
The LLP has its registered office at 5.4.1873 & 4 2Nd Floor Soham Mansion M.G. Road, Secunderabad, Telangana, India – 500003.